IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round

For Digital Subscribers Only

Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY